mcbio,
I did listen to the presentation and the comment about peak years is quite confusing. The woman speaking was talking about a different drug when she said peak sales was 7 years out. She then mentioned peak sales for a second drug, followed finally by Relisor. I doubt peaks sales for all 3 drugs would be 7 years out, so I assume here comment about timing was direct towards the first drug and the timing for the other two drugs, including Relistor, wasn't raised.
I did catch that the Relistor oral formulation would be submitted for approval in July (June?) 2012. Do you have any idea on how quickly formulation change can be approved? Does it take the same amount of time as any new drug submission, or is it quicker?
Market Data 
Markets 
AI
